Directory
>
John Schmid
John Schmid
Board Member and Audit Chair | AnaptysBio
Rancho Santa Fe, California, United States
John Schmid
Summary
John Schmid is a seasoned financial executive and board member with extensive experience in the life sciences sector, particularly in biotech. He has a proven track record of guiding companies through critical phases, including funding, IPOs, and strategic acquisitions. His leadership roles span several biotech firms, where he has served as Audit Chair and Compensation Committee Member, showcasing his expertise in corporate governance and financial oversight. John's background in venture capital and investment banking complements his operational management skills, making him a valuable asset in both private and public company settings. He has successfully navigated complex financial landscapes, raising significant capital and driving company growth. Additionally, he is recognized for his contributions to corporate transitions, having been awarded Director of the Year in 2021. Beyond his professional pursuits, John maintains a strong interest in fostering innovation within the life sciences industry.
John Schmid
Work Experience
Board Member and Audit Chair at
Helix Acquisiton Corp Ii
February 2024 - Present
Board Member, Audit Committee Chair and Compensation Committee Member at
Design Therapeutics
November 2020 - Present
Board Member, Audit Committee Chair, Nom/Gov Committee Member and Lead Independent Director at
Poseida Therapeutics, Inc.
July 2018 - Present
Board Member, Audit Committee Chair, and Compensation Committee Member at
Xeris Pharmaceuticals
September 2017 - Present
Board Member, Audit Committee Chair and Compensation Committee Member at
AnaptysBio
June 2015 - Present
Chairman at
SpeakInc
June 1989 - Present
Board Member at
Blacksmith Medicines, Inc.
May 2017 - April 2024
Board Member and Audit Chair at
Helix Acquisition
October 2020 - April 2022
Board Member, Audit Committee Chair, and Nominating/Governance Committee Member at
Neos Therapeutics
June 2015 - March 2021
Board Member and Audit Committee Chair at
Patara Pharma
May 2016 - August 2018
Chief Financial Officer at
Auspex Pharmaceuticals, Inc.
September 2013 - June 2015
Chief Financial Officer at
Trius Therapeutics
June 2004 - September 2013
Chief Financial Officer at
Geneformatics
January 1998 - January 2003
Chief Financial Officer at
Endonetics
January 1995 - January 1998
Associate at
Idanta Partners
January 1992 - January 1995
Vice President at
HomeFederal Bank
January 1987 - January 1992
John Schmid
Education
January 1990 - January 1992
Wesleyan University, Bachelors
January 1981 - January 1985
Coronado High School
January 1977 - January 1981
Frequently Asked Questions about John Schmid
What is John Schmid email address?
John Schmid's primary email address is *******@speakinc.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does John Schmid work for?
John Schmid is a Board Member and Audit Chair at AnaptysBio, a company specializing in Commercial physical research.
Where John Schmid graduated from?
John Schmid holds a degree in from University of San Diego.
How can I directly contact John Schmid?
To contact John Schmid directly, you can use the email address *******@speakinc.com. Complete contact information is available upon registration with Muraena.
Who is John Schmid?
John Schmid is a seasoned financial executive and board member with extensive experience in the life sciences sector, particularly in biotech. He has a proven track record of guiding companies through critical phases, including funding, IPOs, and strategic acquisitions. His leadership roles span several biotech firms, where he has served as Audit Chair and Compensation Committee Member, showcasing his expertise in corporate governance and financial oversight. John's background in venture capital and investment banking complements his operational management skills, making him a valuable asset in both private and public company settings. He has successfully navigated complex financial landscapes, raising significant capital and driving company growth. Additionally, he is recognized for his contributions to corporate transitions, having been awarded Director of the Year in 2021. Beyond his professional pursuits, John maintains a strong interest in fostering innovation within the life sciences industry.
John`s contact details
*******@speakinc.com
*******@anaptysbio.com
****@forgetherapeutics.com
***********@abbvie.com
**@designtx.com
********@san.rr.com
*******@neostx.com
Colleagues
Chief Medical Officer
VP Buisness Development
VP, Associate General Counsel
Vice President, Target Biology
Vice President, Finance
Executive Director, Regulatory Affairs (CMC)
Vice President Of Quality
SVP, Corporate Affairs
Vice President Regulatory Affairs
Sr. Vice President, Clinical Operations